You are here
Doctoral theses
Doctoral theses lie within the interests of Cemcat with the aim of promoting research into multiple sclerosis. Most theses are directed by Dr. Xavier Montalban, the Director of Cemcat, but also other members of the centre.
Since 2014 until now more than 20 doctoral theses conducted by Cemcat researchers have been presented.
Susceptibility, severity and immunological factors against SARS-COV-2 infection in patients with multiple sclerosis
Ana Zabalza, June 2022
Targeting astrocytes to prevent neurodegeneration in patients with multiple sclerosis
Clara Matute Blanch, October 2021
Immunomodulation of the Th17 pathway as a therapeutic strategy for multiple sclerosis
Marcos Tejero Ambrosio, October 2020
Development of new gene therapy strategies with an immunomodulatory treatment of multiple sclerosis
Ángel Edo Salvador, November 2020
Microbiota as a therapeutic target in multiple sclerosis: preclinical trial of two probiotics and butyrate in two experimental models of multiple sclerosis
Laura Calvo-Barreiro, September 2020
Search for causal genetic variants and study of their functional implications in patients with multiple sclerosis
Elia Gil Varea, November 2018
Usefulness of the measures of cerebral atrophy in the diagnosis and monitoring of multiple sclerosis
Francisco Carlos Pérez Miralles, January 2016
Epidemiology of Multiple Sclerosis in Catalonia
Susana Otero Romero, January 2016
Non Radiological Prognostic Factors of Conversion to Multiple Sclerosis ans Disability in Clinically Isolated Syndromes
Raúl Pelayo Vergara, January 2016
Study of diagnostic and prognostic clinical, biological, and magnetic resonance imaging markers at the time of a clinically isolated síndrome
Georgina Arrambide, March 2016
Study of the roles of genes PERFORIN 1 (PRF1), CASPASE 8 (CASP8) and B-CELL TRANSLOCATION GENE 1 (BTG1) in Multiple Sclerosis
Montserrat Camiña Tato, November 2016
Study of the pseudoatrophy effect in patients with relapsing-remitting multiple sclerosis
Àngela Vidal Jordana, May 2016
Early indicators of response to treatment with interferon in patients with multiple sclerosis
Joaquín Castilló, November 2016
Study of the therapeutic mechanisms in the induction of immunological tolerance in an animal model of multiple sclerosis
Alba Gómez Morago, Fabruary 2016
E Antigen-specific MDSCs induce immunological tolerance in an experimental model of multiple sclerosis. Generation of human MDSCs from hematopoietic progenitors as a therapeutic tool
Sílvia Casacuberta-Serra, Fabruary 2016
Study of the function of the Heat Shock Protein-70 in the pathogenesis of multiple sclerosis
María José Mansilla López, January 2015
Brain volume and brain metabolite changes in the first stages of primary progressive múltiple sclerosis. a short -term longitudinal study
Jaume Sastre, April 2015
Search of prognostic biomarkers in patients with mulitple sclerosis
Sunny Malhotra, January 2014
Function of the 3A and 7A semaphorins in neuroregeneration and in the regulation of immune response to autoimmune encephalomyelitis
Ana Gutiérrez Franco, December 2014
Implication of TLR4 pathway, type I IFNs pathway and monocytes in the clinical response to interferon-beta in multiple sclerosis patients
Marta Fernández Bustamante, December 2014
Search of biomarkers associated with conversion to multiple sclerosis in patients presenting a clinically isolated syndrome
Ester Cantó Puig, December 2014
Clinical and magnetic resonance imaging study of cognitive performance in clinically isolated syndromes suggestive of multiple sclerosis
M Jesús Arévalo Navinés, December 2014
